Navigation Links
Wisconsin First State in Nation to Screen Newborns for 'Bubble Boy Disease'
Date:1/3/2008

The Jeffrey Modell Foundation drives initiative for SCID screening

MILWAUKEE, Jan. 3 /PRNewswire/ -- On Jan. 1, Wisconsin became the first state in the nation to screen all newborns for Severe Combined Immune Deficiency (SCID). Sometimes known as "Bubble Boy Disease," SCID is a genetic disorder that is fatal without early diagnosis and treatment. Babies diagnosed can be referred for potentially life-saving treatment.

The Wisconsin Department of Health and Family Services approved moving to phase two of the pilot screening program in which screening for SCID will be routine for all newborns in Wisconsin (estimated at 70,000 annually). The screening has been added to the current panel of 47 other tests that are given to newborns.

The pilot program began one year ago as a collaborative effort between the Wisconsin State Laboratory of Hygiene at the University of Wisconsin-Madison, Children's Hospital of Wisconsin in Milwaukee and the Jeffrey Modell Foundation. Phase one involved developing a procedure using residual, unidentified blood specimens from Wisconsin's nationally recognized newborn screening program.

"The collaboration between the State Laboratory and Children's Hospital has advanced Wisconsin's health care for newborns at a rapid pace. The outstanding dedication demonstrated by everyone involved is the reason we have progressed to the next phase at a record pace," said Ronald H. Laessig, PhD, emeritus director and professor of Population Health Sciences at the State Laboratory of Hygiene, UW-Madison.

"This complex disease can be cured with a bone marrow transplant if diagnosed early before serious infections develop. That is why the early detection and treatment of SCID through routine screening in newborns will save lives. The screening also will spare infants' repeated and prolonged hospitalizations and save millions of dollars in health care costs. We believe that the Wisconsin Newborn Screening Program will serv
'/>"/>

SOURCE Children's Hospital of Wisconsin
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Francks Compounding Lab Purchases Wisconsin Pharmacy
2. Medical College of Wisconsin study finds drug may limit radiation kidney damage in BMT patients
3. Medical College of Wisconsin receives FDA grant
4. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
5. March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis
6. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
7. Corazonas Launches First and Only Cholesterol-Reducing Potato Chips
8. Put Safety First During Winter Fun
9. Methodist Mansfield Celebrates First Year
10. AspenBio Outlines Steps for FDA 510(k) Clearance of AppyScore(TM), the First Blood-Based Screen/Triage Test for Human Appendicitis
11. First reputable book on the history of the Paralympic Movement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...ptember 5, 2008Private Medicare Advantage (MA) pla...nrollee in 2008 compared to what the same enrollee...or-service program, according to a new report from...tions to MA plans mandated by the Medicare Improve...A) scheduled to take effect beginning in 2010 ha...
(Date:9/4/2008)...ence of instructions they say could help doctors e...lthDay News) -- Vaccine safety experts say that al...eive vaccinations with close monitoring and a set ...ptember issue of Pediatrics , a team of experts l...h a step-by-step set of instructions -- an algorit...
(Date:9/4/2008)... Medelis, an oncology contract research organ...linical Trials: A Nuanced Approach to Get Into the...cGarry, a preclinical research scientist with 35 y...ical studies are commonly viewed as straightforwar...o operate without true integration with preclinica...
(Date:9/4/2008)... of Palestinian and Israeli teenagers, art from,Ar...wire/ -- America must take a major,role in finding...he world,says Ira Magaziner, chair of the William...ior White House Advisor for Policy Development in ...e speaker at a conference at,Massachusetts School ...
Breaking Medicine News(10 mins):Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 2Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 4
...m the university of Michigan state that Women who ...more likely than nonsmokers to give birth// to a b...rth defect rises with the number of cigarettes tha...ors like the mother's race, age and educational le...
...gthening drug fosamax (Bifosa) was initially laude...sis. But doctors discovered that patients often st...igid dosing instructions: It was supposed to be ta...ed with plenty of water. To top it off, the drug c...
...nsity lipoprotein(LPD), lipid composition and anti...liability to oxidation of LDL derived from diabeti...re the oxidation of LDL drawn from patients with d... also sought to follow-up the effects of dietary b...
...hat women have yet another good reason to exercise...for so many things. It reduces our risk of heart d...s levels. Now a new study says it's also good for ... Right now screening tests for ovarian cancer are ...
Other Medicine News:
(Date:9/4/2008)...INGHAM, Ala., Sept. 4 /- Southern Res...Institutes of Health (NIH) has selected,the organi...r Libraries,Probe Production Center Network (MLPCN...- is part of the Molecular Libraries Program which...ntific knowledge of the human,genome and validate ...
(Date:9/4/2008)... cohort demonstrates potent antiviral activity and...ofile -, CAMBRIDGE, Mass., Sept. 4 /PRNewswire-Fi... IDIX ), a biopharmaceutical company engaged,in th...ment of human viral,and other infectious diseases,...f-concept study evaluating IDX899, a non-nucleosid...
(Date:9/3/2008)...ays: Wrong Question Asked. Wrong Children Studied....PRNewswire-USNewswire/ -- A Centers for Disease,Co...aims there is no link,between the MMR vaccine and ... this study does nothing to dispel the growing pub...aises several questions concerning design,and meth...
(Date:9/3/2008)... September is National Vascular Disease Awarenes...e/ -- Diffusion Pharmaceuticals,LLC, a clinical-st...rugs,for the treatment of unmet medical needs, ann...in a Phase I/II clinical trial of its lead drug,ca... designated NCT00725881,on the clinicaltrials.gov ...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4China Clean Energy Updates Business Outlook 6279 1China Clean Energy Updates Business Outlook 6279 2China Clean Energy Updates Business Outlook 6279 3New York Resident Elected President of Lions Clubs International 22871 1New York Resident Elected President of Lions Clubs International 22871 2Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 1Medical Machines Online Announces the Overstock and Release of a New ECG Machine 22868 2Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 1Urgent Care Provider NextCare Introduces CareForToday Medical Insurance Plan 22865 2
...nts with,predominantly classic subfoveal choroid... the Opal Photoactivator from,Lumenis. Developed...or injection) therapy, the Opal Photoactivator,o...tures,that ensure the highest level of patient c...
Features soft, low friction sheath that extends beyond the tip.
Designed to retain the desired curve during oral intubation.
SunGlide™ Stylette - Grey Child. Use in 4.0 to 7mm tubes. 25/box.
Medicine Products: